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MMR vaccination and autism 1998
There is no causal link between MMR
vaccine and autism
Editor—Nichol et al considerably understate
their case when they write “chance alone dic›
tates that some cases [of autism] will appear
shortly after vaccination.”1 Such a temporal
association is unremarkable, given the epi›
demiology of autism and MMR vaccine.
Over the time described by Wakefield et
al2 MMR vaccine was given to around
600 000 children each year in Britain3 and
the prevalence of autistic spectrum dis›
orders was 91/100 000.4
Assuming that the diagnosis of autism is
evenly distributed over the second and third
years of life and that the incidence over this
period approximates to the current preva›
lence,5 over the eight years that the reported
cases represent autism would have been diag›
nosed in around 364 cases in the two months
after MMR vaccination (the time that
the authors regard as noteworthy—(((91/
100 000) × 600 000) × 8) × (2/24) = 364). The
reported cases therefore represent a fraction
of the cases of autism whose onset coincides
with the administration of MMR vaccine.
R Roberts Consultant in public health medicine
North Wales Health Authority, Preswylfa, Mold,
Flintshire CH7 1PZ
1 Nicoll A, Elliman D, Ross E. MMR vaccination and autism
1998. BMJ 1998;316:715›6. (7 March)
2 Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson
DM, Malik M, et al. Ileal›lymphoid›nodular hyperplasia,
non›specific colitis, and pervasive developmental disorders
in children. Lancet 1998:351:637›41.
3 Chen RT, DeSteffano F. Vaccine adverse events: causal or
coincidental? Lancet 1998, 351:611›2.
4 National Autistic Society, Update on prevalence of autistic
spectrum disorders. London: NAS, 1997. (Press release.)
5 Wing L. Autistic Society Spectrum Disorders: No evidence
for or against an increase in prevalence. BMJ 1996;
312:327›8.
Those giving MMR vaccine had no input
into editorial
Editor—The editorial by Nicoll et al about a
possible link between measles, mumps, and
rubella (MMR) vaccine and autism1 is not
helpful for those working in primary care
who actually give the vaccine, are concerned
about its potential and actual side effects,
and have to deal with the effects of a scare
story, as in this case. General practitioners,
health visitors, and practice nurses, who all
give this vaccine regularly, have had no
formal input into the editorial and have not
participated in the expert committee set up
to review the MMR reports.
It is all very well to ask an expert com›
mittee for an opinion based on research in
secondary, and even tertiary, care. A more
valuable opinion of what really happens in
practice, however, would be available from
those who actually have the day to day
experience of this vaccine in use, and that
includes parents.
Public concern about the safety of MMR
vaccine has not only been raised by the study
of Wakefield et al.2 In 1992 and 1993 one of
the commonly used MMR vaccines was with›
drawn because of recurrent reports of
adverse effects. I remember seeing three cases
of encephalitis after MMR vaccinations in my
own baby clinic at that time, although thank›
fully these resolved.
Concerns after a television advertisement
for the MR booster campaign in 1994 and
1995 left parents wondering whether the
advertisement was meant to scare them into
having the vaccination done. This may
explain in part the media response to
Wakefield’s study.2
What we would have needed from the
editorial were some straightforward figures
to help parents understand why their child
should have this vaccine. An unvaccinated
child is 20 times more likely to have a
serious complication from measles, mumps,
or rubella than he or she would be after
MMR vaccination.
Finally, I assume that the last paragraph
of the editorial contains an error: “While
vaccine can be guaranteed to be without any
risk . . . .”1 No vaccine or drug can ever be
guaranteed to be without any risk.
M R Kiln General practitioner
Rosendale Surgery, London SE21 8EZ
1 Nicoll A, Elliman D, Ross E. MMR Vaccination and autism
1998. BMJ 1998;316:715›6. (7 March.)
2 Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson
DM, Malik M, et al. Ileal›lymphoid›nodular hyperplasia,
non›specific colitis and pervasive development disorder in
children. Lancet 1998;351:637›41.
Medical practitioners need to give more
than reassurance
Editor—Can I present a challenge to Nicoll
et al?1 As a parent of young children I have
become aware of a website—“The informed
parent” (http://www.unc.edu/∼aphillip/
WNW/vaccine/dvm.txt)—that is having a
profound influence on many of my non›
medical friends who have small children.
Although the website is written by a
non›physician, it is written in the style of a
medical journal, which lends it more author›
ity than it may merit. This website argues that
vaccination is dangerous and unnecessary.
The issue is about risk and the
perception of risk. There may also be a per›
ception of secrecy about problems with vac›
cines in the United Kingdom, which is why
this website is now so influential. In a
consumer led NHS it is no longer sufficient
for general practitioners and practice nurses
to give simple reassurance.
The challenge is to produce information
for parents that is accessible (including on
the internet) and balanced, and that
addresses the specific concerns that websites
such as “The informed parent” engender.
This is a particular example of patient
empowerment, and the medical profession
needs to do more than just convince itself of
the safety of vaccination.
J Selway Senior registrar in public health
Edensor, Tunbridge Wells, Kent TN1 5QL
1 Nicoll A, Elliman D, Ross E. MMR Vaccination and autism
1998. BMJ 1998;316:715›6. (7 March.)
The health of Gypsies
Problem of caring for travellers is British,
not just European
Editor—The editorial by McKee1 on
Gypsies, or Romas, was an interesting factual
account of their origins as well as of the
disadvantages and oppression they face as a
minority group in continental Europe. Yet it
is remarkable in that there is no mention of
the disadvantages and oppression endured
by the same minority community in the
United Kingdom—from the Romas of folk›
lore in the south of England to the tinkers of
Scotland and to the New Age wanderers who
seem to seek the romantic image without the
responsibilities. Now they travel in trucks
towing large caravans; when parked they are
usually seen in lay›bys or on waste ground
with lots of dogs, children, and rubbish.
In these unofficial caravan sites they live
in the squalor and type of conditions
prevailing in this country a couple of centu›
ries ago—no clean or adequate water supply,
no sewage disposal system, no rubbish
collection, and certainly totally inadequate
education, immunisation, and medical atten›
tion. The reaction is often to “get rid of
them,” preferably by moving them on to
some rundown housing estate in the next
town but one. Local authorities have a duty
to provide proper sites for travelling people,
although this is too often frustrated by the
“not in my back yard” (“nimby”) attitude and
an inability of local authorities to attempt to
work with the Gypsy culture by cooperating
with their lifestyle.
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It is easy to be disapproving about the
unwelcome refugees in and around Dover.
As far as our own travellers are concerned, it
is a sad reflection on our society, and
perhaps on the BMJ, that we behave as if
nothing needs to be done in this country
although it seems to be agreed that much
needs to be done across the channel.
G A C Binnie General practitioner, retired
Ladykirk, Norham, Berwick upon Tweed TD15 1XL
1 McKee M. The health of gypsies. BMJ 1997;315:1172›3. (8
November.)
Governments and Roma communities
must help to improve outlook for Gypsies
Editor—In his editorial on the health of
Gypsies—an important minority in central
and eastern Europe—McKee states that
“health policymakers and researchers have
paid little attention to the health needs of
Roma people.”1 This is not true. The
communist regime in the former Czechoslo›
vakia spent considerable sums to improve
the economic, health, and housing situation
of the “proletarian” Roma population.
Infant mortality of Gypsies decreased
considerably and the number of Gypsies liv›
ing in Slovakia more than trebled from the
end of the second world war to 1990.2
Health care as well as the educational system
in Slovakia was free and equally available to
all Slovaks, Hungarians, and Gypsies. After
the change from a socialist economy to a
free market economy, unemployment
among the Roma minority rapidly
increased. The main reason was not racism
but the low educational level and low work›
ing activity of Gypsies.
In 1996 we performed sociological
research in various parts of Slovakia by a
Gallup method. The table summarises some
data from a representative sample of 1016
men aged 25›55 living in the multiethnic
district of Levice on the border with
Hungary (about 65% Slovaks, 30% Hungar›
ians, and 5% Gypsies). The data are similar
for both Slovaks and Hungarians and very
different for Roma men: the Roma minority
had an extremely high consumption of ciga›
rettes, beer, and spirits; low consumption of
milk, fruit, and vegetables; a lower cultural
level; a higher prevalence of sleep disorders;
a lower health status; and a high birth rate.
Although Roma people continue to exist
on the margins of society and their life
expectancy is low, the number of Gypsies in
Slovakia increased by 1›2 % a year between
1991 and 1996.3 The reason for the high
reproductive activity in Roma people is an
economic one—regular financial support
from state sources for each child. If this trend
does not change, the Roma minority in 2010
will form about a fifth of the young and mid›
dle aged population in Slovakia. Most
Gypsies will have only elementary education
and will be unemployed, chronically ill, and
dependent on financial support from the
state. A huge increase in crime could be
expected, and the final result could well be an
increase in racist attacks, ethnic conflicts, and
an exodus of Gypsies to the “rich” West.
Prevention of this pessimistic scenario is
not in the hands of health policymakers and
medical researchers. Extensive educational
programmes, control of the birth rate, new
economic chances, and a change of lifestyle
are the best that east European governments
and Roma communities themselves could
do for the health needs and the future of
Roma people.
Emil Ginter Head of Epidemiology
Institute of Preventive and Clinical Medicine, 83301
Bratislava, Slovakia
1 McKee M. The health of gypsies. BMJ 1997;315:1172›3. (8
November.)
2 Srb V. Roma people in Czechoslovakia according to
census 1991. Demografie 1993;35:282›9.
3 Statistical Office of the Slovak Republic. Statistical yearbook
of the Slovak Republic 1966. Bratislava: SOSR, 1996.
Citalopram is safe
Editor—Power comments on my assertion
that all selective serotonin reuptake inhibi›
tors seem safe in overdose,1 citing six
published cases of suicide in which citalo›
pram was strongly suggested to have caused
death. Although no drug is absolutely safe in
overdose, the relative safety of the selective
serotonin reuptake inhibitors compared
with tricyclic antidepressants in this regard
has been shown by many years of clinical
experience.2
Citalopram is the most widely prescribed
antidepressant in Sweden, and the Swedish
Poisons Information Centre at the Karolinska
Hospital has reported data on 104 cases of
“pure” citalopram overdose treated in Swed›
ish hospitals in 1995›6.3 Nausea, dizziness,
and drowsiness were seen in patients who
had ingested up to 30 times the usual
therapeutic dose of 20 mg. In cases where up
to 95 times the usual therapeutic dose was
taken seizures and electrocardiograpic
abnormalities were reported, but there were
no deaths or serious arrhythmias. The largest
overdose in this series was equivalent to over
9 months’ treatment at 20 mg daily, showing
considerable determination on the part of the
patient, who made a full recovery.
The authors of the study concluded that
most citalopram overdoses have an unevent›
ful course.3 An overdose of 4000 mg of
apparently “pure” citalopram resulting in
death4 was of similar size to a reported fatal
overdose of fluoxetine taken alone.5 Power
reasonably concludes that the true safety of
a drug in overdose cannot fully be
determined until the drug has seen exten›
sive clinical use. Citalopram has been
available in some countries since 1989, and
it is estimated to have been used in routine
clinical practice in almost 8 million patients.
Thus there seems to me no reason to
question the safety profile of citalopram any
more than that of other selective serotonin
uptake inhibitors.
A S Hale Consultant psychiatrist
Thanet Community Mental Health Care,
Westbrook Centre, Margate, Kent CT9 5DD
1 Power A. Drug treatment of depression. BMJ 1998;316:
307›8. (24 January.)
2 Glassman AH. Citalopram toxicity, Lancet 1997;350:318.
3 Perssone M, Perssone H, Sjoberg G. Citalopram toxicity.
Lancet 1997;350:518›9.
4 Oström M, Eriksson A, Thorson J, Spigser O. Fatal
overdose with citalopram. Lancet 1996;348:339›40.
5 Kincaid RL, McMuillin MN, Crockham SB, Reiders F.
Report of a fluoxetine fatility. J Anal Toxicol 1990;14:327›9.
Removing intravascular lines at
72 hours allows need for
antibiotics to be reassessed
Editor—Randolph et al’s meta›analysis
suggests that continuous infusions of low
dose heparin prolong the patency of arterial
and venous peripheral catheters.1 This is
encouraging for both patients with needle
phobia and junior doctors. The authors do
not, however, emphasise the risks of invasive
vascular devices, particularly the infective
risks.
Although some studies disagree, it is
widely accepted that rates of phlebitis and
infection (both local and systemic) associ›
ated with intravascular lines are related to
the duration of insertion.2 The American
Hospital Infection Control Practices Advi›
sory Committee strongly recommends
Differences between Gypsies, Slovaks, and Hungarians living in Slovakia (district of Levice), 1996.
Figures are number (percentages) of positive answers
Slovaks Hungarians Gypsies
No of respondents 655 314 47
Age (SD) (years) 37.9 (8.5) 38.4 (8.3) 38.0 (8.4)
Responses to questions asked
Daily or almost daily consumption of:
Milk and milk products 286 (43.6) 140 (44.6) 12 (25.5)
Fruit 285 (43.5) 151 (48.0) 9 (19.2)
Vegetables 280 (42.8) 171 (54.5) 15 (31.9)
Beer 189 (28.8) 75 (23.9) 23 (49.0)
Spirits 67 (10.2) 30 (9.6) 11 (23.4)
Often in conflicts with other people 87 (13.3) 44 (14.0) 16 (34.0)
Agreed with statement “I have no chance to influence my future” 70 (10.7) 34 (10.8) 13 (27.7)
Poor health status 51 (7.8) 22 (7.0) 10 (21.3)
Sleep disorders 53 (8.1) 30 (9.6) 8 (17.0)
Almost no reading of newspapers 178 (27.1) 55 (17.5) 23 (48.9)
No book read during past year 262 (40.0) 146 (46.5) 35 (74.5)
Smoker 329 (50.2) 167 (53.2) 37 (78.7)
Father of more than two children 91 (13.9) 43 (13.7) 24 (51.1)
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replacing peripheral venous catheters in
adults every 48›72 hours.
The problem of hospital acquired infec›
tion related to intravascular lines should not
be underestimated. A recent survey by the
Public Health Laboratory Service found that
invasive devices constituted by far the most
important risk factor for hospital acquired
infection.3 From our own unpublished
figures we found that 37% of cases of hospi›
tal acquired bacteraemia over two months
were related to an intravascular line. Of
these, 14% were associated with peripheral
venous catheters; these catheters were prob›
ably underrepresented, because peripheral
line tips are submitted for microbiological
analysis infrequently.
In addition, the increasing rates of colo›
nisation of hospital inpatients with resistant
organisms, particularly methicillin resistant
Staphylococcus aureus, are producing a con›
comitant increase in resistant bacteraemia
related to lines.4 Analysis of bacteraemias
within our trust over 17 months showed that
31% of all bacteraemias due to S aureus were
resistant to methicillin.
Showing that the use of continuous
infusions helps to decrease phlebitis is
encouraging, and the decreased frequency
of handling of the catheter hub site would
reduce the risk of contamination—now a
recognised factor in the pathogenesis of
infection associated with intravascular
devices.5 However, we would strongly advise
against allowing the lack of visible inflam›
mation to lead to continued use of
peripheral intravenous lines. A policy of
removing lines at 72 hours would allow con›
sideration of the need for continued
antibiotics or for switching to oral treatment
with the attendant cost savings, patient com›
fort, and possible earlier discharge.
M Ruddy Specialist registrar
C C Kibbler Consultant
Department of Medical Microbiology, Royal Free
Hospital, London NW3 2QG
1 Randolph A, Cook DJ, Gonzales CA, Andrew M. Benefit of
heparin in peripheral venous and arterial catheters:
systemic review and meta›analysis of randomised control›
led trials. BMJ 1998;316:969›75. (28 March.)
2 Pearson ML. Guideline for prevention of intravascular
device related infections. Infect Control Hosp Epidemiol
1996;17:438›73.
3 Glynn AA, Ward V, Wilson J, Charlett A, Cookson B, Taylor
L, et al. Hospital acquired infection: surveillance, policies, and
practice. London: Public Health Laboratory Service, 1997.
4 Tabaqchali S. Vancomycin resistant Staphylococcus
aureus; apocalypse now? Lancet 1997;350:1644.
5 deCicco M, Chiaradia V, Veronesi A, Santini G, Panarello
G, Fracasso A, et al. Source and route of microbial coloni›
zation of parenteral nutrition catheters. Lancet
1989;ii:1258›61.
Exceptionalism in HIV
Challenge for Africa too
Editor—The 24 January issue on antenatal
HIV testing emphasised the need to promote
routine voluntary HIV counselling and
testing to maximise the opportunity for inter›
ventions in those found to be infected. More
than 20 million of the 30 million people esti›
mated to be infected with HIV at the end of
1997 live in sub›Saharan Africa, where some
spend less than $15 (£9) per capita on health
each year and over 90% of those infected are
unaware of their infection. The opportunities
for the medical interventions discussed are
therefore limited.
Nevertheless, although individual ben›
efits may be small, the potential benefits for
society are huge. HIV/AIDS “exceptional›
ism” in parts of Africa has led to an environ›
ment of stigma and denial, with the tacit
support of policy makers and healthcare staff.
HIV is rarely entered in African death certifi›
cates, yet treatment decisions are made on the
assumption that a patient is infected. Half of
those counselling others to consider HIV
testing choose not to be tested themselves.1
Fewer than half those tested feel able to tell
their sexual partner that they have been
tested, whatever the result.2 Many people
assume that they are infected and that testing
would merely increase despondency. Only
7% of couples invited for counselling and
testing in Lusaka decided to have a test.3
Normalisation, as defined by De Cock
and Johnson, would be an important step in
improving the environment for preventing
HIV transmission.4 However, to maximise
the impact of HIV testing on prevention it
needs to be promoted earlier. Women
attending antenatal clinics provide an
opportunity for screening. However, if
anti›retroviral drugs are not available and if
strong financial, cultural, and public health
considerations make avoiding breast feeding
difficult, the distress and anxiety caused by
discovery of a women’s HIV seropositivity
when she is already pregnant may outweigh
the benefits. Promotion of voluntary HIV
testing for young people before they are
pregnant or sick would offer greater chances
of preventing transmission.
Among clients of TASO, the largest
AIDS support organisation in Africa, the
most commonly cited advantage of being
tested was access to the centre’s basic medi›
cal service.5 In Lusaka, the most common
reason for declining a test was that no medi›
cal intervention was available.3 Prophylaxis
against tuberculosis is beneficial to HIV
positive people even in areas of high
tuberculosis transmission. Thus, relatively
small and low cost improvements to the care
and support offered to HIV positive people
could enhance demand for testing and help
to bring HIV back to normality in Africa too.
Peter Godfrey›Faussett Senior lecturer
London School of Hygiene and Tropical Medicine,
London WC1E 7HT
Rachel Baggaley Consultant
Unit of AIDS and Sexually Transmitted Diseases,
World Health Organisation, Geneva, Switzerland
baggaleyr@who.ch
1 Baggaley R, Sulwe J, Ndovi›Macmillan M, Godfrey›Faussett
P. HIV counsellors’ knowledge and attitudes and
vulnerabilities to HIV. AIDS Care 1996;8:155›66.
2 Kelly M, Baggaley R. Voluntary HIV counselling in Lusaka,
Zambia. Who comes, why and does it help? [Abstract No
519B/D]. Tenth international conference on AIDS Yokohama,
August 1994. Tokyo: Japanese Foundation of AIDS Preven›
tion, 1994.
3 Baggaley R, Sulwe J, Bennett J, Ndovi›Macmillan M, Kelly
M. Barriers to HIV counselling and testing in Chawama,
Lusaka, Zambia. International conference on AIDS/STDs in
Africa, Kampala, December 1995. Kampala, Uganda: Society
on AIDS in Africa, 1995.
4 De Cock KM, Johnson A. From exceptionalism to
normalisation: a reappraisal of attitutdes and practice
around HIV testing. BMJ 1998;316:290›3. (24 January.)
5 Tanzanian AIDS Support Organisation, World Health
Organisation. TASO Uganda the inside story.Geneva: WHO,
1995. (WHO/GPA/HCS/95.1.)
Past experience has been ignored
Editor—De Cock and Johnson propose the
“normalisation” of current HIV testing prac›
tice, which they describe as “exceptional›
ism.”1 This description of the past flagrant
disregard of epidemiological and ethical
principle sounds impressive, and the
authors go on to state that this policy of
exceptionalism had the support of, among
other groups named, “physicians.”
The fact is that many doctors disagreed
with BMA resolutions on HIV testing
policies, which defied common logic and
morality. Clear issues of disease manage›
ment were obfuscated by unethical and
irrelevant arguments about citizens’ legal,
civil, and personal rights. Rational thinking
fell prey to vocal lay pressure groups.
Emotive expressions such as horrible dis›
ease, fatal illness, social stigma, employment
threat, insurance risk, informed consent, and
other newly coined phrases became
grounds for advising patients not to have
HIV tests in case the result was positive.
Legal “experts” pronounced on hypothetical
situations never contested in court. Doctors
seemed frightened into forgetting that less
than half a century ago syphilis, gonorrhoea,
tuberculosis, and smallpox were horrible,
unpleasant, and (except gonorrhoea) com›
monly fatal diseases without known effective
drug treatment.
The tried principles of our predecessors
were ignored, and the authors rightly
mention that the legal matter of responsibil›
ity for all this may now become a matter of
negligence. This country has untraceable
women citizens who have tested HIV
positive. There are counselled people who
have refused tests and may be HIV positive.
Spouses, partners, and others are at risk, and
babies, lacking effective drug protection, will
be born HIV positive. The public will soon
perceive the immorality of using anony›
mous antenatal blood samples for obtaining
central government HIV statistics. Changes
must be immediate.
HIV testing should become routine for
antenatal clinics. Counselling should be
reserved for HIV positive patients. Similar
testing should become routine at all sexually
transmitted disease clinics.
This country is fortunate that HIV has
proved less infectious than at first was
feared. Britain could have had a major pub›
lic health problem. Before marrying in
America many years ago, I required a certifi›
cate of negative syphilis serology. My wife,
during pregnancies, was neither asked nor
counselled before she was tested for syphilis
in Britain. Ian Grant’s prophetic letter in
19882 should be reprinted.
M F Brewster Retired general practitioner
Dunure, Wigtown, Wigtownshire, DG8 9DZ
1 De Cock KM, Johnson A. From exceptionalism to
normalisation: a reappraisal of attitudes and practice
around HIV testing. BMJ 1998;316:290›3. (24 January.)
2 Grant IWB. Consensus on HIV testing.BMJ 1988;297:356.
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CAGE questionnaire allows
doctors to avoid focusing on
specifics of drinking
Editor—Perhaps I should be flattered that
my CAGE questionnaire is so popular that
the BMJ printed it twice in 1997—though
without proper attribution on both occasions.
One of the articles by Ashworth and Gerada
in the ABC of Mental Health uses the CAGE
questionnaire as if it had just appeared out of
nowhere rather than being the result of clini›
cal studies and efforts to develop a brief and
easily remembered series of questions.1 The
citation should have been given.2
Ashworth and Gerada should read a
paper by Steinweg and Worth, who write:
“Our study demonstrates the negative
impact of asking patients to discuss the spe›
cifics of their drinking. Not only can it make
for an uncomfortable interview, it is diagnos›
tically self defeating. The CAGE questions
offer the physician powerful tools to avoid
focusing on the specifics of drinking.
However, important keys to the CAGE are
open ended introductions and resisting the
urge to ask the patient to quantitate
consumption.”3 Ashworth and Gerada do
the opposite in their recommendations.
After a focus on amount, time, and pattern
of consumption they say: “Specific question›
ing should continue with the CAGE
questionnaire.” I think that study of Steinweg
and Worth’s paper will persuade them to
change their recommendations.
John A Ewing Professor emeritus of psychiatry,
University of North Carolina
2311 Canterwood Drive, Wilmington, NC 28401,
USA
1 Ashworth M, Gerada C. ABC of Mental Health: Addiction
and dependence—II: Alcohol. BMJ 1997;315:358›60.
2 Ewing JA. Detecting alcoholism—the CAGE questionnaire.
JAMA 1984;252:1905›7.
3 Steinweg DL, Worth H. Alcoholism: the keys to the CAGE.
Am J Med 1993;94:520›3.
Audit Commission tackles
anaesthetic services
Anaesthesia should remain physician
based service.
Editor—We read with interest the articles1 2
that you recently published in response to
the Audit Commission’s Anaesthesia under
Examination,3 which revisits the topic of
nurse anaesthetists. We trained as anaesthet›
ists in the United Kingdom but now work in
the United States.
Nurse anaesthetists in the United States
always work under the direction of a
physician and, despite our initial reservations,
we have all been pleasantly surprised by the
experience of working with this highly
qualified group of professionals. Minimal
requirements for entry to the training
programmes of two to three years are a nurs›
ing or basic science college degree and one
year’s experience in critical care nursing. Fear
of unemployment in recent years has
produced a sharp fall in applications to
anaesthesia residency programmes.4 Most
programmes have downsized, and a few have
closed altogether. Rather than appoint more
consultants, many hospitals have recruited
nurse anaesthetists to meet their commit›
ments—an expensive solution as salaries for
nurse anaesthetists, which average £50 000,
are more than twice those of residents.
The US Health Care Financing Admin›
istration recently announced a proposal to
eliminate the federal requirement for super›
vision of nurse anaesthetists by physicians.
This move is being supported by the Ameri›
can Association of Nurse Anesthetists. If
approved, the proposal could allow inde›
pendent practice in some states. The Ameri›
can Society of Anesthesiologists has urged
its members to respond “vigorously” to the
proposal.
Why can’t nurses be a part of anaesthe›
sia in Britain? The simple answer is: “It’s too
late.” Assuming that a pool of sufficiently
trained and motivated nurses who are
willing to take up the challenge actually
exists, will there be any jobs for them by the
time they emerge from training? Who
should train and accredit nurse
anaesthetists—and could recruitment to
nurse anaesthesia deprive other areas of its
skilled practitioners? Unlike his or her
American counterpart, the average British
trainee in anaesthesia often works with little
or no supervision. British trainees are paid
less than their regular rates of pay for
contractual overtime. We believe that it is
unlikely that nurses would tolerate being
used to replace trainees in anaesthesia
under the same conditions. Employing
nurses as replacements for consultants,
which could conceivably happen in the
United States, would threaten the funda›
mental involvement of the practice of medi›
cine in anaesthesia.
The practice of anaesthesia is much
more than the administration of anaesthet›
ics and for this reason anaesthesia should
remain, at least in the United Kingdom, a
physician based service.
Joseph E Arrowsmith Visiting associate
Ratan Alexander Visiting associate
Guy de Lisle Dear Assistant professor
Tong Joo Gan Assistant professor
Robert P Hill Visiting associate
Adeyemi Olufolabi Visiting associate
Iain C Sanderson Assistant professor
Andrew J Soppitt Visiting associate
Department of Anesthesiology, Duke University
Medical Center, Durham, NC›27710, USA
1 Smith A. Audit Commission tackles anaesthetic services.
BMJ 1998;316:3›4. (3 January.)
2 Wise J. NHS urged to appoint nurse anaesthetists. BMJ
1998;316:10. (3 January.)
3 Audit Commission. Anaesthesia under examination. London:
AC, 1997.
4 Grogono AW. Update on residents and their prospects in
1997. American Society of Anesthesiologists Newsletter
1997;61(12):17›9.
Non›physician anaesthetists may free up
consultants to concentrate on patients
requiring special attention
Editor—Smith’s editorial gives an overview
of the Audit Commission’s report on anaes›
thetic services.1 Inevitably, however, headline
reporting in both the lay and the medical
press concentrated on the report’s
recommendation to consider the introduc›
tion of non›physician anaesthetists into Brit›
ish practice. Smith points out the firm
opposition of the Association of Anaesthe›
tists to this—a result of concerns over the
safety of patients, legal ambiguities, and
cost.2 Rather than being seen as a threat,
however, the report should act as an impetus
for anaesthesia in the United Kingdom to
reconsider this entrenched, “closed shop”
attitude.
Much routine minor and intermediate
surgery performed on fit patients does not
require the presence of a fully trained
consultant anaesthetist for the entire dura›
tion. The training guidelines of the Royal
College of Anaesthetists3 suggest that, after
an introductory module of 12 weeks,
medically qualified trainees may have “level
2” supervision for some straightforward
cases. This is defined as: “Trainer present in
the operating theatre suite . . . available to
assist or advise.”
Historically, much routine work has
been done by trainee anaesthetists under
the (sometimes fairly distant) supervision of
consultants. As a result of the Calman
reforms and limits on working hours this
service contribution from trainee doctors is
being reduced drastically. At the same time,
the demands on anaesthesia services are
growing constantly. The answer to this prob›
lem should not be simply to seek ever
increasing numbers of consultant anaesthe›
tists to perform undemanding work, but
rather to encourage the development of
non›physician anaesthesia practitioners,
trained and supervised by medically quali›
fied anaesthetists. Surely, a nurse or other
medical professional who would undertake
two or three years’ training in anaesthesia
could provide care at least equivalent to that
of a trainee doctor.
This would provide consultant anaes›
thetists working both in and out of operating
theatres time to concentrate on those
patients who require the benefit of their
medical training and extended specialist
experience.
D N Robinson Fellow in paediatric anaesthesia
HCI (Scotland), Clydebank G81 4HX
1 Smith A. Audit Commission tackles anaesthetic services.
BMJ 1998;316:3›4. (3 January.)
2 Association of Anaesthetists. Anaesthesia in Great Britain
and Ireland: a physician only service. London: AAGBI, 1994.
3 The Royal College of Anaesthetists. Specialist Training in
Anaesthesia, Supervision and Assessment. London: RCA,
1994.
Quoted paper did not say that
participation of nurses makes adverse
outcomes more common
Editor—In his editorial1 Smith quoted a
paper that I cowrote2 to support his
argument that adverse outcomes in anaes›
thesia are more common when anaesthetics
are given by nurse anaesthetists.
Our article did not mention anything of
this sort. We had conducted a retrospective
analysis of all reports that an anaesthetic
department of a university hospital made to
the faults, accidents and near accidents
committee of that hospital over 10 years.
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We did not analyse the data on the basis
of who gave the anaesthetics. This was irrel›
evant for our study since it is the practice in
all university hospitals in the Netherlands
that anaesthesia is given by a team
consisting of an anaesthesia trainee and an
anaesthetic nurse under the direct supervi›
sion of a qualified specialist anaesthetist. It is
unfortunate that our study has been
misquoted in support of the argument that
nurse anaesthetists are not as safe as medical
anaesthesiologists.
V Chopra Consultant anaesthetist
Leiden University Medical Centre, 2300 RC Leiden,
Netherlands.
1 Smith A. Audit commission tackles anaesthetic services.
BMJ 1998;316: 3›4. (3 January.)
2 Chopra V, Bovill JG, Spierdijk J. Accidents, near accidents
and complications during anaesthesia. A retrospective
analysis of a 10›year period in a teaching hospital.
Anaesthesia 1990;45:3›6.
Investment is required to increase
number of consultant anaesthetists
Editor—I am used to seeing misrepresenta›
tive headlines in the tabloid press but am
surprised to see one in the BMJ.1 The Audit
Commission’s wide ranging report Anaesthe›
sia under Examination makes no mention of
urging the NHS to appoint nurse anaesthe›
tists as the title of Wise’s article suggests.2
The report does recognise that one
obvious way to reduce the demand for more
doctors substantially is to allow non›medical
staff to administer anaesthesia. This cannot
be argued with. The actual recommenda›
tions, however, are much more tentative and
suggest that hospitals such as small district
general hospitals, with few trainees or
perhaps none at all, might benefit from a
trial of using non›physician anaesthetists (or
physicians’ assistants, as they are called in
some parts of the United States) to help the
lone consultant. This would involve an
extension of the role of the anaesthetic
nurse or operating department assistant to a
more active role in the maintenance of
anaesthesia. In certain circumstances this
might lead to the consultant supervising two
operating theatres at one time, with suitable
staff and a suitable case mix.
This system might well be acceptable to
some consultants without any trainees, who
must be willing to take on the additional
responsibility and should be paid appropri›
ately to do so. But it is patently not the
traditional role of the nurse anaesthetist in
the United States, where many small
hospitals are virtually autonomous and only
nominally under the charge of a surgeon, let
alone an anaesthetist. I suspect that few
patients in the United Kingdom would be
willing to accept this arrangement.
A survey of staffing in anaesthesia showed
that the United Kingdom (and the Republic
of Ireland) has by far the lowest number of
consultants per 100 000 population (4.6 in
the UK v 10.8 in 17 European countries).3
Despite the much higher number of consult›
ants (with fewer trainees) in the rest of
Europe, however, greater use is made there
of anaesthesia nurses (15.5/100 000 in
Germany and about 23/100 000 in Norway
and Sweden). So no cost savings are made.
Thus international evidence shows
clearly that as (or if) the number of trainees is
reduced a massive investment is required in
consultant anaesthetists to bring the United
Kingdom into line with the rest of Europe.
Only when this has occurred is a trial with
non›physician anaesthetists warranted.
D W Green Consultant anaesthetist
King’s College Hospital NHS Trust, London
SE5 9RS
1 Wise J. NHS urged to appoint nurse anaesthetists. BMJ
1998;316:10. (3 January.)
2 Audit Commission. Anaesthesia under examination.London:
AC, 1997.
3 Rolly G, MacRae WR, Blunnie WP, Dupont M, Scherpereel
P. Anaethesiological manpower in Europe. Eur J Anaesthe›
siol 1996;13:325›32.
Experience is paramount for
successful management of
disease
Editor—Earlier this week the medical firm
on which I am registrar was on general medi›
cal intake. After a quiet day things began to
get busy around 11 pm. Two patients with
suspected oesophageal varices and haemate›
mesis arrived almost simultaneously. Both
had signs of cardiovascular compromise.
Around midnight a woman with an anterior
myocardial infarct was given thrombolysis. At
2 30 am the same patient developed transient
complete heart block and pulmonary
oedema, then ventricular tachycardia fol›
lowed by atrial fibrillation. Too short of breath
to lie flat for transvenous pacing, she was suc›
cessfully managed with an external pacing
device, followed by intravenous amiodarone
and carefully titrated doses of intravenous
nitrates.
Our firm comprises one house officer,
two senior house officers, and a registrar,
and at the time of writing it had a third sen›
ior house officer funded from the contin›
gency money that we received from the
government to deal with a potential winter
crisis. To comply with the new deal for junior
doctors’ hours the house officer goes to bed
at midnight and the senior house officers
split the night, only one being up at a time.
Accordingly I, as the duty registrar, managed
all of the ill patients described above. The
duty senior house officer was clerking
patients who had taken overdoses or had
other less acute problems for most of the
night and was therefore unable to be present
with me. As a fairly experienced registrar I
have managed similar cases countless times
before. I am experienced at staying awake
and managing patients “hands on” when
needed, as was no doubt the case here.
What is disturbing is that not one of the
four doctors junior to me on the firm learnt
anything about the management of patients
with acute serious illness that night. In three
years from now I might be a consultant.
Those doctors, deprived of experience by the
new deal, may be medical registrars. My own
mother will be approaching the same age as
the patient with the infarct. From the time of
Hippocrates experience has been recognised
as paramount for the successful management
of disease. Are our mothers and fathers to be
managed by inexperienced doctors?
Martin Dumskyj Specialist registrar in general
medicine, diabetes, and endocrinology
Kingston Hospital, Kingston upon Thames
KT2 7QB
Urgency and priority models
Model has limited practical application
Editor—The recent interest in priority
scoring for surgical operations is to be com›
mended. The paper by the Northern Ireland
Clinical Resource Efficiency Support Team
highlights the differences between “urgency”
and “priority” and how demographic and
lifestyle related details may influence the
timing of coronary artery bypass surgery.1
Unfortunately this model has limited practi›
cal application.
Firstly, although the opinion of the
referring doctor is important, the ultimate
responsibility for prioritising the waiting list
lies with the cardiac surgeons, who repre›
sented only a minority of the judges (4 out
of 33). Furthermore, the study does not take
into account how cardiac surgeons organise
their waiting lists. Some run their list
individually and some operate a joint
waiting list; most would separate the list into
emergency, urgent, and routine cases, but
few would adopt a more sophisticated prior›
ity system within each group. This is not to
say such an approach would be wrong, but it
would imply a constant reshuffling of
patients as the list grew and would make
it impossible to give patients a reasonable
estimate of their wait.
Secondly, inspection of the angiogram is
an integral part of patient assessment, but
this was denied to the judges in this study.
Simply recording the number of severely
diseased vessels fails to take into account the
importance of the anatomical location of
the stenoses, the dominance of the coronary
vessels, and their relative size. A stenosis of
the proximal left anterior descending artery
in association with a tight proximal circum›
flex stenosis would be assigned more
urgency and priority than perhaps a stenosis
of the distal left anterior descending artery
in combination with disease in the posterior
descending artery—yet both are examples of
two vessel disease. This point is particularly
identified in a study from New Zealand.2
Finally, the success of interventional
cardiology creates an increasing number of
grey areas. The option to treat surgically or by
endovascular intervention may be biased by
the relative length of the waiting list for each
technique and by the patient’s own wishes, as
much as by the clinical need for intervention.
Although the model presented allows
those deciding about waiting lists some
insights into how others view the surgical
treatment of coronary artery disease, the
decisions made were based on insufficient
clinical data and may not reflect current
practice. Unfortunately, this model also fails
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to recognise the key role of the cardiac sur›
geon as the “gate keeper” of the waiting list.
Ian M Mitchell Consultant cardiothoracic surgeon
David W Quinn Research fellow
Nottingham City Hospital, Nottingham NG5 1PB
1 Kee F, McDonald P, Kirwan JR, Patterson CC, Love AHG.
Urgency and priority for cardiac surgery: a clinical
judgment analysis. BMJ 1998;316:925›9. (21 March.)
2 Hadorn DC, Holmes AC. The New Zealand priority
criteria project. Part 2: Coronary artery bypass graft
surgery. BMJ 1997;314:135›7.
Distinction between urgency and priority
helps no one
Editor—Kee et al distinguish between
urgency and priority in patients waiting for
coronary artery bypass surgery.1
In practice such a distinction is so fine as
to be pointless; the most urgent patients
receive the highest priority. It is not necessary
to convene workshops and invoke paper
patients to determine urgency. The amount
of research on coronary artery bypass
surgery allows the survival benefits over
medical treatment to be defined precisely.2
For example, patients with three vessel
coronary artery disease and angina of class III
or IV have a one year survival of 94% after
coronary artery bypass surgery and of 85% if
treated medically.2 If these patients are kept
on a waiting list for one year twice as many
will die as would if they underwent immediate
surgery. This calculation can be made for any
patient in whom the bypass operation affords
prognostic benefit, which allows prioritisation
in a quantifiable way.
We have analysed a random sample of
67 patients from one health district who
underwent coronary artery bypass grafting
between 1 April 1996 and 31 December
1997. The reason for the operation was to
improve prognosis, regardless of the severity
of symptoms (class 1), or to improve
symptoms alone, as defined by the Ameri›
can College of Cardiology and American
Heart Association (class 2).2 In 56 patients
the bypass operation conferred a survival
advantage. These patients had a shorter wait
than those operated on for symptoms alone
(table). Those with the most threatening
coronary artery disease and the worst symp›
toms had the shortest wait (table).
Nevertheless the 25 patients with three
vessel disease and class III or IV angina still
waited a median of 81 days (interquartile
range 38 to 169).
We believe that these data show that the
priority given to these patients is appro›
priate, given what is known of the clinical
course of coronary artery disease. We also
believe that some of these waiting times are
unacceptable. No amount of “clinical judg›
ment analysis” can alter this. Waiting lists can
be reduced only by increasing the number
of operations or denying surgery to certain
patients who currently benefit. Muddying
the waters with academic distinctions
between urgency and priority and the effect
that “lifestyle characteristics” have on this
helps no one—our patients least of all.
Philip Wraighte Medical student
University of Sheffield, Sheffield S10 2RX
Walter Rhoden Consultant cardiologist
Barnsley District General Hospital, Barnsley
S75 2EP
Graham Cooper Consultant cardiothoracic surgeon
Northern General Hospital, Sheffield S5 7AU
1 Kee F, McDonald P, Kirwan JR, Patterson CC, Love AHG.
Urgency and priority for cardiac surgery: a clinical
judgment analysis. BMJ 1998;316:925›9. (21 March.)
2 Kirklin JW, Akins CW, Blackstone EH, Booth DC, Califf
RM, Cohen LF, et al. ACC/AHA guidelines and
indications for coronary artery bypass graft surgery.
Circulation 1991;83;1125›73.
Clinical and economic
arguments favour extension to
upper age limit for breast
screening
Editor—In an editorial Sutton argues that
the upper age limit of 64 for breast
screening is illogical, and he ascribes it to
ageism.1 This may be true, but there is no
economic rationale for limiting routine
screening to women below the age of 65.
Indeed, the most cost effective age in terms
of cost per life year saved by breast screening
is 70.2 We have recently set out the economic
arguments for extending breast screening to
women aged over 643; some of them bear
repeating. Firstly, there is the issue of poor
compliance with screening. The level of
compliance with any screening programme
is an economic issue only if those who do
not comply are at higher risk than those who
do, which for breast screening does not
seem to be the case.4 Secondly, poor compli›
ance is sometimes wrongly associated with
non›attendance. Non›attendance wastes
screening resources, but if the national
breast screening service were to use an
efficient appointment method that required
women to confirm their intention to attend
then non›attendance could be reduced to
negligible levels.5 Thus absolute levels of
compliance for breast screening are largely
irrelevant for cost effective screening.4 For
instance, if compliance of 90% produces a
fall in deaths from breast cancer of 30% then
a compliance level of 45% that reduces
deaths by 15% at half the cost is still cost
effective.4 The reason that breast screening
has not been extended to older women is
probably confusion of screening objectives
rather than ageism. Compliance with
screening has been implicitly and explicitly
set as a key objective when really the
ultimate objective of screening should be a
reduction in mortality and morbidity from
the disease.4 One reason why screening of
older women has not been adopted, despite
the overwhelming clinical and economic
arguments for it, is resource limitation. This,
however, can be addressed by simply
abandoning screening for women aged
50›53 and redirecting the resources to
women aged 66›69. Such a policy would
increase the numbers of life years saved by
5% at no extra cost.3
David J Torgerson Senior research fellow
National Primary Care Research and Development
Centre, Centre for Health Economics, University of
York, York YO1 5DD
Toby Gosden Research fellow
National Primary Care Research and Development
Centre, University of Manchester, Manchester
M13 9PL
1 Sutton GC. Will you still need me, will you still screen me,
when I’m past 64? BMJ 1887;315:1032›3. (25 October.)
2 Brown ML. Economic considerations in breast cancer
screening of older women. J Gerontol 1992;47:51›8.
3 Torgerson DJ, Gosden T. Is the national breast screening
service inefficient? Q J Med 1997;90:423›5.
4 Torgerson DJ, Donaldson C. An economic view of high
compliance as a screening objective. BMJ 1994;308:117›9.
5 Torgerson DJ, Garton MJ, Donaldson C, Reid DM, Russell
IT. Recruitment methods for screening programmes: trial
of an improved method within a regional osteoporosis
study. BMJ 1993;307:99.
Gamete donors for IVF should
relinquish right of ownership
to resulting embryos
Editor—The Human Fertilisation and
Embryology Act states that gamete donors
have rights over the destiny of their gametes
and any embryos resulting from their use.1
Donors are volunteers, who are given a full
explanation of the use of their gametes for
clinical or research purposes. After counsel›
ling, donors proceed to donation only if they
are in full agreement about the use of their
gametes, which extends to deciding the fate of
any resulting embryos from their donation.
The length of time that embryos can be
stored by cryopreservation has recently
been extended from five to 10 years,
provided that the natural parents of the fro›
zen embryos consent to this. It is essential
that both parents agree about the length of
cryopreservation. In cases in which one of
the natural parents is a donor, his or her
agreement must be obtained before the fate
of the frozen embryos is decided, whatever
the other natural parent may wish.
We recently encountered a difficult
situation. A couple receiving in vitro
fertilisation with donated sperm had eight
Median waiting times (in days) for coronary artery bypass surgery (with interquartile ranges)
Treatment category Overall
Angina*
3 vessel disease Proximal LAD disease
Left main
stem stenosisclass II class III class IV
Class 1 (n=56)† 84 (41 to 194) 190 (116 to 297) 104 (50 to 219) 42 (15 to 72)F 119 (50 to 243) 71 (39 to 167) 61 (40 to 92)
Class 2 (n=11)‡ 232 (130 to 247) 236 (232 to 239)§ 130 (119 to 141)¶ 221* (195 to 246)¶ NA NA NA
LAD=left anterior descending coronary artery. NA=not applicable. *According to classification of Canadian Cardiovascular Society. †Prognostic benefit with or without symptomatic benefit.
‡Symptomatic benefit only. §Three patients. ¶Four patients.
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embryos frozen at the end of treatment,
which were still frozen at the end of the ini›
tial five year storage period. The donor
could not be contacted to provide consent to
further storage. Although the female part›
ner was the natural mother of the frozen
embryos, because the sperm donor could
not be contacted and the patients did not
wish to put the matter before the law an
extension to embryo storage could not be
allowed and the embryos were destroyed.
To prevent this situation arising again, we
believe that after treatment the responsibility
for donated gametes should be accepted by
the patient or couple to whom they are
donated. The fate of embryos resulting from
gamete donation should be decided solely by
the patient or couple, after counselling.
A change in the Human Fertilisation
and Embryology Act is necessary to reflect
these views and to strengthen the rights of
patients as to the fate of donated gametes
and resulting embryos. Gamete donors con›
senting to the use of their gametes for clini›
cal purposes should relinquish the right of
ownership for any resulting embryos to the
couple for whom the embryos are intended.
This will effectively give the patients sole
authority over the fate of frozen embryos.
M R Gazvani Research fellow
A J M Thomson Research fellow
S J Wood Research fellow
C R Kingsland Director, consultant obstetrician and
gynaecologist
Reproductive Medicine Unit, Liverpool Women’s
Hospital, Liverpool L8 7SS
D I Lewis›Jones Senior lecturer in obstetrics and
gynaecology
Department of Obstetrics and Gynaecology,
University of Liverpool, Liverpool
1 Human Fertilisation and Embryology Act (1990) schedule 3.
London: HMSO, 1990.
Water fluoridation is safe and
effective
Editor—I was not surprised that Gibson and
Gibson1 had to rely on a paper published 50
years ago to support their claim that water
fluoridation was not effective in preventing
tooth decay and that it was harmful to health.
However, the paper they cited2 did not
mention either a delay in tooth eruption or
an increase in infant mortality, both of which
they claim have been shown to be associated
with fluoridation.
Gibson and Gibson are correct in identi›
fying some areas where water is not
fluoridated as areas with good dental health.
Tooth decay is, like many other diseases, asso›
ciated with social deprivation. In Britain there
is also a gradient of dental health that runs
from north to south. Children in middle class
areas in the south east would therefore be
expected to have lower rates of dental caries.
In 1995›96, eight of the 11 health
authorities with the lowest prevalence of
tooth decay among 5 year olds received
fluoridated water, while nationally just over
10% of the country has fluoridated water. At
the other end of the league table no district
in which more than 25% of the population
drink fluoridated water has even half as
much dental decay as the worst area that
does not drink fluoridated water.
In their paper on fluoridation and social
deprivation Jones et al3 caution against bas›
ing claims on selective quotation from the
literature. Selective misquotation and misin›
terpretation need even more vigorous
rebuttal. The scientific evidence is clear.
Fluoridation is both effective and safe. Public
opinion surveys confirm that the over›
whelming majority of the population are in
favour of water fluoridation.4 It is time that
the UK government took action to prevent
the privatised water companies from having
a veto over public health policies that have
been set by health authorities as a result of
extensive consultation.
John F Beal Consultant in dental public health
Leeds Health Authority, Leeds LS1 4PL
1 Gibson SLM, Gibson RG. Water fluoridation and tooth
decay in 5 year olds: authors did not compare like with like.
BMJ 1998;316:231. (17 January.)
2 Weaver R. The inhibition of dental caries by fluorine. Proc
R Soc Med 1948;41:284›90.
3 Jones CM, Taylor GO, Whittle JG, Evans D, Trotter DP.
Water fluoridation, tooth decay in five year olds, and social
deprivation measured by the Jarman score: analysis of data
from British dental surveys. BMJ 1997;315:514›7. (30
August.)
4 British Fluoridation Society. Briefing on public attitudes
towards fluoridation. Liverpool: BFS, 1992.
Filters inserted into the vena
cava may be useful for some
indications
Editor—Minerva suggests that a study
published in the New England Journal of Medi›
cine on the insertion of a filter into the vena
cava to prevent pulmonary embolism casts
doubt on the value of this treatment.1 In this
study patients with proximal deep vein
thrombosis, deemed to be at high risk of pul›
monary embolism, were randomly assigned
either to have a filter inserted or to treatment
with low molecular weight heparin. Most
interventional radiologists in the United
Kingdom would not recognise this diagnosis
as a clear indication for insertion of a filter.
The indications commonly treated in this way
in the United Kingdom are proven pulmo›
nary embolism occurring despite adequate
treatment with anticoagulant drugs, contrain›
dications to treatment with anticoagulant
drugs with demonstrable thrombosis in the
femoral or iliac veins, complications of
treatment with anticoagulant drugs requiring
discontinuation of treatment, or proximal
thrombosis in the iliac vein or vena cava in
patients about to undergo surgery (for exam›
ple, pelvic reconstruction after trauma).2
While it is true that randomised studies
are lacking, it is equally true that it would be
difficult ethically to assign patients randomly
to treatment given the accepted indications
in the United Kingdom. The study shows
that filters reduce but do not eliminate the
occurrence of pulmonary embolism, which
is encouraging, but it did not find a
reduction in mortality. This would suggest
that filters should not be employed as first
line treatment in the population that was
studied; this finding is not surprising. I do
not believe, however, that this data should be
used to discourage the use of filters to treat
those indications described above since the
study design did not address those issues.
Mark G Cowling Lecturer in interventional radiology
Division of Radiological Sciences, United Medical
and Dental Schools of Guy’s and St Thomas’s
Hospitals, Guy’s Hospital, London SE1 9RT
1 Minerva. BMJ 1998;316:788. (7 March.)
2 Belli A›M, Buckenham T. Vascular intervention: inferior
vena cava filters. In: Watkinson A, Adam A, eds.
Interventional radiology: a practical guide. Oxford: Radcliffe
Medical Press, 1996.
Providing letters to patients
Patients find summary letters useful
Editor—Essex raises some interesting
points about the value of giving patients a
written summary of their consultation.1 The
practice of sending patients a letter summa›
rising their consultation is very common in
genetic counselling.
A colleague and I have completed a
qualitative interview study exploring patients’
attitudes about and their use of written
summaries of their genetic consultations for
hereditary breast and ovarian cancer.2 Like
Essex, we found that patients responded very
positively to these letters. Altogether 37 (93%)
out of 40 patients in the sample said that the
summary letter aided their understanding or
recall of information that had been given in
the clinic, or both. The written summary was
also perceived as valuable because it could be
shown to other clinicians to support the
patient’s case for gaining access to breast or
ovarian screening programmes, it reassured
patients that they were taking appropriate
action, and it contained information about
other relatives’ risks. In addition, the written
summary was also perceived as a useful tool
for disseminating genetic information to
other family members; 34 (85%) out of 40
patients said they had used, or intended to
use, the written summary of their counselling
session to facilitate the communication of
genetic information to other biological
relatives.
On the basis of our findings we suggest
that genetic counsellors send patients a letter
summarising their consultations as this may
result not only in an increase in the patient’s
understanding, but may prevent the miscom›
munication of genetic information within the
family. However, we feel that clinicians should
be aware that providing patients with a
written summary of their consultation may
also have negative consequences. It may gen›
erate an inappropriate demand for referrals
to genetic clinics from family members at low
risk, and, more importantly, reading a letter
written to the patient may cause needless
anxiety among low risk family members.
N Hallowell Senior research associate
Centre for Family Research, Faculty of Social and
Political Sciences, University of Cambridge,
Cambridge CB2 3RF
1 Essex C. Consultants could give patients a letter summaris›
ing their consultation. BMJ 1998;316:706. (28 February.)
2 Hallowell N, Murton F. The value of written summaries of
genetic consultations.Patient Education Counselling (In press.)
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GPs can be given copies of letters sent to
patients
Editor—I would like to reinforce Essex’s
opinion that consultants should write letters
to their patients summarising their findings
after a consultation.1 Since starting the breast
screening service in South Essex in 1990, it
has been my policy to write to women who
have been assessed and whose abnormalities
have been found not to require surgical
evaluation or treatment.
Initially, I also wrote letters to the
woman’s general practitioner but I have
since found this to be an unnecessary waste
of resources. I now write to the woman and
send a copy of the letter to her general
practitioner. This ensures that the general
practitioner knows exactly what the woman
has been told and it provides a record of the
procedures undertaken and the advice given
on future management.
There has been a mixed reception to the
letters. One group of general practitioners
praised their clarity while another com›
plained about their technical detail. I hope
modifications made in response to these
comments have made the letters more com›
prehensible to both the women and their
general practitioners.
M D Lewars Consultant radiologist
South Essex Breast Screening Service, Westcliff on
Sea, Essex SS0 0SB
1 Essex C. Consultants could give patients a letter summaris›
ing their consultation. BMJ 1998;316:706. (28 February.)
Summary letters may be especially
appropriate after emergency admissions
Editor—It is common for professionals such
as accountants and solicitors to follow a
meeting with a client with a letter recapitulat›
ing the points discussed, and Essex is to be
congratulated on his initiative in doing the
same after paediatric outpatient appoint›
ments.1 Communication is especially impor›
tant at either end of the age spectrum, and
some years ago two of the four geriatric teams
in our hospital decided to send out letters to
patients who had been seen for consultations.
The letters were sent after the initial visit and
also when results came back or decisions
were arrived at which might have made a fur›
ther letter helpful. Altogether, 79% of 35
patients found the letters “very helpful” and
18% found them “helpful.” Questionnaires
were also sent to 38 patients in a control
group. In this group, 74% indicated that a let›
ter would have been “very helpful” and 23%
indicated that it would have been “helpful.”
We sent separate letters to the patients’
general practitioners together with a copy of
the letter sent to the patient.
It was a valuable exercise in communi›
cation skills, but we had to discontinue the
practice due to the need to reduce the
secretarial (and medical) workload. Perhaps
it would be even more useful to send a
similar letter after an emergency admission,
since so much of what has happened
becomes eclipsed by subsequent events, and
memories of procedures and discussions so
readily become blurred.
Nicholas Coni Consultant geriatrician
Department of Medicine for the Elderly,
Addenbrooke’s Hospital, Cambridge CB2 2QQ
1 Essex C. Consultants could give patients a letter summaris›
ing their consultation. BMJ 1998:316:706. (28 February.)
Letters should be used carefully
Editor—We were interested to read that
Essex advocates giving patients a letter sum›
marising their outpatient consultation.1 Sev›
eral authors have already conducted
research in this area.2 3 We agree that it is of
paramount importance that doctors com›
municate with patients to ensure patient sat›
isfaction and enhance the relationship
between doctor and patient. However, if we
were to send each patient a letter summaris›
ing their consultation the workload that
would be generated would be unacceptable
both from the medical and secretarial view›
point, and this procedure is unlikely to be
economically viable.
In our work with gastroenterology
patients attending outpatient appointments
we found that large numbers of patients
wanted to receive more information about
their condition, its investigation, and its
management.4 We achieved the same degree
of patient satisfaction by providing patients
with a copy of the letter that was sent to their
general practitioner as when we posted
them a separate, tailor made letter.
There are many benefits to patients
receiving a copy of the letter sent to their
general practitioner: they are able to build
their own copy of their medical record, their
knowledge increases, and it reminds them of
the details of the consultation (as we all
know patients may find it difficult to recall
details of consultations especially when the
subject is emotive).
As patients want more information it
becomes our duty to provide it. However,
when communicating with patients by send›
ing them copies of letters sent to their general
practitioners the potential for generating
anxiety is introduced as some patients will
have serious diseases. We advocate sending
patients a letter to reinforce what has already
been discussed during an outpatient consul›
tation, but believe that doctors should be
careful of introducing new information or
breaking bad news in a letter as this would be
unethical and uncaring.
J A Eaden Research fellow
B Ward Audit assistant
J F Mayberry Consultant physician
Gastrointestinal Research Unit, Leicester General
Hospital, Leicester LE5 4PW
1 Essex C. Consultants could give patients a letter summaris›
ing their consultation. BMJ 1998;316:706. (28 February.)
2 Rylance G. Patients’ right to know. BMJ 1990;300:608›9.
3 Tattersall R. Writing for and to patients. Diabetic Med
1990;10:917›9.
4 Eaden JA, Ward B, Smith H, Mayberry JF. Are we telling
patients enough ? A pilot study to assess patient information
needs in a gastroenterology outpatient department. Eur J
Gastroenterology Hepatology 1998;10:63›7.
Cover picture meant that BMJ
had descended to level of
tabloid newspapers
Editor—It was with deep regret that I saw
the cover picture for the issue of 6 June. The
issues raised by the Bristol case are matters
that have grave implications for the whole of
the profession.1 It raised many difficult ques›
tions, which the BMA and other profes›
sional bodies are seeking to address both in
depth and with great urgency.
To sensationalise the issue is unneces›
sary and deeply offensive to many members
of the association. Consultants are only too
aware of the great personal tragedy that has
affected the families of the children in the
Bristol case but nevertheless will be sad›
dened to see a learned journal descend to
the level of the tabloid newspapers.
J N Johnson Chairman, Central Consultants and
Specialists Committee
BMA, London WC1H 9JP
1 Treasure T. Lessons from the Bristol case. BMJ 1998;316:
1085›6. (6 June.)
*** The BMJ publishes cover pictures to draw
attention to the journal publishing a cluster of
material on a subject. Our experience is that
readers like the occasional use of cover
pictures. When we do publish a cover picture
we find as strong an image as we can to illus›
trate the material. Last week’s issue contained
nine papers that moved on the debate that
the Bristol case has started, a debate that may
prove to be one of the most important in
British medicine this century. We wanted to
ensure that readers knew about these articles,
and so we decided to publish a cover picture.
It was an obvious thing to do to use a strong
picture associated with the Bristol case.
Whether or not the cover is tabloid is a
matter of opinion; to my mind it simply
shows a grieving mother. But nobody could
argue that the content, which is what
matters most, is tabloid. And the good thing
about tabloids is that millions of people
read them, whereas the bad thing about
many scientific journals is that nobody
reads them, not even scientists—Editor.
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